Nasdaq · CIK 0001680048
MBIO MUSTANG BIO, INC.
Insider trading from SEC Form 4. Last filing Jan 5, 2026. Close $0.40 on Oct 9, 2026, 0% from the 52-week low and -77% from the high.
MUSTANG BIO, INC. (MBIO) has 7 SEC Form 4 filings on file from 5 insiders, the latest filed on Jan 5, 2026. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
3 open-market trades have been scored at MBIO. The newest: Adam J. Chill (director) sold $4 of stock on Dec 30, 2025, filed Dec 30, 2025, scored 23 (weak). The largest of the 3 shown: Neil Herskowitz (director) sold $238 on Dec 30, 2025, scored 43 (moderate). 2 insiders sold within 14 days of each other around Dec 30, 2025.
MBIO closed at $0.40 on Oct 9, 2026, 0% above its 52-week low and 77% below its 52-week high.
Last 90 days
Price and insider trades, last year
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at MUSTANG BIO, INC., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 23Weak | Adam J. Chill director sell | $4 4 shares | -1% | - | |
| 43Moderate | Neil Herskowitz director sell | $238 247 shares | -63% | - | |
| 25Weak | David Jin director buy | $238 247 shares | +633% | - |
Transactions
Every row filed, 7 in all.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 2, 2026 | Fortress Biotech, Inc. owner | AGrant or award COMMON STOCK, PAR VALUE $0.0001 | +278,385 | $0.00 | $0 | 536,577 | Jan 5, 2026 |
| Dec 30, 2025 | Adam J. Chill director | SOpen-market sale COMMON STOCK, PAR VALUE $0.0001 | -4 | $0.95 | $4 | 375 | Dec 30, 2025 |
| Dec 30, 2025 | Neil Herskowitz director | SOpen-market sale COMMON STOCK, PAR VALUE $0.0001 | -247 | $0.96 | $238 | 145 | Dec 30, 2025 |
| Dec 30, 2025 | David Jin director | POpen-market purchase COMMON STOCK, PAR VALUE $0.0001 | +247 | $0.96 | $238 | 286 | Dec 30, 2025 |
| Sep 29, 2025 | Fortress Biotech, Inc. owner | AGrant or award COMMON STOCK, PAR VALUE $0.0001 | +59,334 | $0.00 | $0 | 258,192 | Oct 1, 2025 |
| Apr 24, 2025 | Manuel Litchman MD President, CEO and Interim CFO | FTax withholding COMMON STOCK | -27 | $1.24 | $33 | 1,634 | Apr 28, 2025 |
| Mar 31, 2025 | Fortress Biotech, Inc. owner | AGrant or award COMMON STOCK, PAR VALUE $0.0001 | +67,806 | $0.00 | $0 | 198,858 | Apr 2, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Adam J. Chilldirector
- Fortress Biotech, Inc.owner
- Neil Herskowitzdirector
- David Jincfo, officer, director
- Manuel Litchman MDPresident, CEO and Interim CFO
Questions about MBIO
Answered from the filings on this page, as of the latest one.
Are insiders buying MBIO?
No. In the last 90 days no insider at MUSTANG BIO, INC. bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade MBIO on the open market?
Adam J. Chill (director) sold $4 of MBIO on Dec 30, 2025 and filed the Form 4 on Dec 30, 2025. InsiderTell scored 23 (weak), with 2 insiders on the same side within 14 days.
How many insiders file Form 4 at MUSTANG BIO, INC.?
5 people have filed a Form 4 at MUSTANG BIO, INC., among them Adam J. Chill (director), Fortress Biotech, Inc. (10% owner), Neil Herskowitz (director). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.